FDA Reconsiders ORA Reorganization As Questions From Congress Continue
This article was originally published in The Tan Sheet
Executive Summary
FDA's Aug. 1 decision to temporarily suspend plans to close seven of its 13 field laboratories as part of its Office of Regulatory Affairs reorganization follows repeated protests and inquiries from Capitol Hill, including a July 31 letter from two of the proposal's chief critics
You may also be interested in...
ORA Lab Closings Cancelled But Reorganization Not Off The Table – Staffers
FDA's head of regulatory affairs' Aug. 17 message to staff about cancelling plans to close seven field labs did not mark the end of the agency's ORA reorganization work, staff members say
ORA Lab Closings Cancelled But Reorganization Not Off The Table – Staffers
FDA's head of regulatory affairs' Aug. 17 message to staff about cancelling plans to close seven field labs did not mark the end of the agency's ORA reorganization work, staff members say
ORA Lab Closings Cancelled But Reorganization Not Off The Table – Staffers
FDA's head of regulatory affairs' Aug. 17 message to staff about cancelling plans to close seven field labs did not mark the end of the agency's ORA reorganization work, staff members say